Reliant AI develops an AI workbench designed to speed data processing in the biopharma sector. The platform helps life-science analysts find scientific evidence via automated systematic reviews, asset scans, comprehensive analyses, and a customizable data platform. The team describes the product as enabling arbitrary queries across datasets to support decision-making. The company was founded by Karl Moritz Hermann, Marc Bellemare, and Richard Schlegel and is based in Berlin and Montreal (Canada). Reliant AI received $11.3 million in investment from Tola Capital, Inovia Capital, and Mike Volpi. The article does not disclose revenue, user counts, or other operating metrics.

Total raised

$11M

Funding rounds

1

Latest round

Equity

Latest activity

Aug 2024